Liquid composition for electronic cigarettes and electronic cigarettes having the same
The electronic cigarette liquid composition with cannabinoids and piperine addresses sleep, anxiety, and smoking cessation without THC, offering a synergistic effect for improved sleep quality and reduced anxiety and pain.
Patent Information
- Application Number
- JP2020117452
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-07-08
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2040-07-08
AI Technical Summary
Existing electronic cigarettes do not effectively address sleep, anxiety, pain, and smoking cessation effects, and they fail to break psychological dependence on nicotine, while compositions containing THC pose health risks.
A liquid composition for electronic cigarettes containing cannabinoids extracted from hemp stems or seeds, piperine, and a solvent, with a specific weight ratio, providing a synergistic effect for sleep, anxiety relief, pain reduction, and smoking cessation without THC.
The composition, when inhaled through electronic cigarettes, enhances sleep quality, reduces anxiety, alleviates pain, and aids in smoking cessation by leveraging the synergistic effects of cannabinoids and piperine, suitable for both healthy individuals and those with medical conditions.
Smart Images

Figure 0007578936000001 
Figure 0007578936000002
Abstract
Description
[Technical field]
[0001] The present invention relates to a liquid composition for electronic cigarettes that contains at least a cannabinoid and piperine, and an electronic cigarette having the same. [Background technology]
[0002] The hemp plant is also called cannabis or hemp grass, and its leaves and flowers in particular contain tetrahydrocannabinol (THC), which has a unique effect on humans. Therefore, dried hemp leaves or flowers are sometimes called "cannabis" and have been used since ancient times.
[0003] Patent Document 1 describes a "TRP channel blocker" that contains the cannabinoids "a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC)," and describes that the blocker relieves neuropathic pain, inflammation, vasoconstriction, etc., and further describes that these two types of cannabinoids are extracted (produced) from cannabis. However, this "TRP channel blocker" contains tetrahydrocannabinol (THC) as an essential ingredient, and the blocking of the TRP channel was confirmed in a Petri dish. There is no description of administration via the human respiratory tract, and the alleviation of the above-mentioned symptoms was not directly confirmed in humans.
[0004] Patent Document 2 describes a health food that combines CBD oil and fucoidan, claiming that the combination of these ingredients produces a synergistic effect that can normalize and activate cells in the human body. However, in addition to the fact that "CBD oil" contains tetrahydrocannabinol (THC), which is generally considered dangerous, Patent Document 2 makes no mention of administration via the respiratory tract, nor does it mention or suggest e-cigarettes.
[0005] Patent Document 3 describes an extract containing cannabinoids and terpenes / flavonoids, the "cannabinoids" being at least four types of cannabinoids. However, the invention described in Patent Document 3 is characterized by the extraction method and the content ratio of the four types, among which tetrahydrocannabinol (THC), which is generally considered dangerous, is included as an option, and it is administered via juice or smoothie.
[0006] Patent Document 4 describes a composition containing a cannabinoid, a propellant, alcohol, etc., and also describes that the composition is administered to the lungs in the form of an aerosol having fine particles. However, the composition of Patent Document 4 provides an option for tetrahydrocannabinol (THC), and provides a method for treating subjects suffering from diseases or disorders such as neuropathic pain, motion sickness, arthritis, and "neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis," but does not provide both a stimulating effect and a sedative effect on humans, particularly healthy people.
[0007] Piperine, on the other hand, is a type of alkaloid that gives black pepper its pungent taste and has been used in traditional medicine and as an insecticide.
[0008] Cited Document 5 describes an invention relating to a method for controlling bleeding by administering a vanillin receptor agonist (VRA), and lists cannabinoids and piperine as exemplary compounds of the VRA. However, these are merely listed as having the same effect, and there is no mention or suggestion of a synergistic effect between these two compounds in D5. Moreover, the method of administration is local administration to damaged blood vessels, and the problem, purpose, effect, and use of the invention are all different from those of the liquid composition for electronic cigarettes.
[0009] Reference 6 describes microparticles in the form of a core-shell, and lists cannabidiol (CBD) and piperine as active agents contained in the core. However, the problem and purpose of the invention described in Reference 6 is to form a core-shell morphology to provide an effective dose to a target site in the gastrointestinal tract, and these two compounds are merely listed as examples of active agents that can be used. In addition, the microparticles in Reference 6 are orally administered agents, and therefore the problem and purpose, effects, and uses of the invention are all different from those of the liquid composition for electronic cigarettes.
[0010] In recent years, the number of intellectual workers has increased and people want to be awake, but at the same time, people also want to be calm and sleep well because of the increased stress. However, there have been few products that have been effective enough to achieve this. Furthermore, there have been no products that use electronic cigarettes to achieve the effects of good sleep, pain relief, and anxiety relief. In other words, there has been no method that can easily and conveniently reduce anxiety, pain, and the like.
[0011] Furthermore, many people want to quit smoking in order to break their dependency on cigarettes that contain nicotine. Dependence on cigarettes can be divided into physical dependence (nicotine dependence) and psychological dependence (behavioral dependence). Of these, psychological dependence is due to habits and habit, and tends to become stronger the longer one smokes. Most conventional nicotine-free electronic cigarettes have focused on medically breaking away from nicotine dependence, and almost none have focused on the psychological dependence (behavioral dependence). [Prior art documents] [Patent documents]
[0012] [Patent Document 1] International Publication No. 2008 / 129258 [Patent Document 2] JP 2017-079615 A [Patent Document 3] International Publication No. 2016 / 064987 [Patent Document 4] JP 2018-150334 A [Patent Document 5] Special Publication No. 2007-525431 [Patent Document 6] Special Publication No. 2019-513146 Summary of the Invention [Problem to be solved by the invention]
[0013] The present invention has been made in view of the above-mentioned background art, and an object of the present invention is to solve the above-mentioned problems and to provide a liquid composition which, when ingested by a human being, has a sleep-inducing effect, an anxiety-suppressing effect, a sedative effect, a pain-suppressing effect, an anti-smoking effect, and the like, as well as a method for ingesting the same and an ingestion tool (instrument) for the same. [Means for solving the problem]
[0014] As a result of intensive research into solving the above-mentioned problems, the inventors decided to use an electronic cigarette as the device to be ingested into the body via the respiratory system (lungs), and further discovered that by containing at least both a cannabinoid and piperine as a liquid composition for the electronic cigarette (liquid for electronic cigarettes), it is possible to achieve sleep-inducing effects, anxiety-suppressing effects, sedative effects, pain-suppressing effects, smoking cessation effects, etc., and thus completed the present invention.
[0015] That is, the present invention provides a liquid composition for electronic cigarettes that releases an active ingredient contained in the liquid composition by heating the liquid composition, The present invention provides a liquid composition for electronic cigarettes, which is characterized by containing at least a cannabinoid contained in hemp stems or seeds, piperine, and a solvent.
[0016] The present invention also provides a liquid composition for electronic cigarettes, wherein the cannabinoid is at least one cannabinoid selected from the group consisting of cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabielsoin (CBE), cannabigerol (CBG), and cannabidivarin (CBDV), extracted from the stems or seeds of hemp.
[0017] The present invention also provides a liquid composition for electronic cigarettes, wherein the cannabinoid dissolved in the liquid composition for electronic cigarettes is derived from crystals of cannabidiol (CBD) extracted from hemp stems or seeds.
[0018] The present invention also provides the liquid composition for electronic cigarettes, which contains the cannabinoid and the piperine in a ratio by mass ranging from 9.5:0.5 to 2:8.
[0019] The present invention also provides a liquid composition for electronic cigarettes, comprising 1 part by mass or more and 300 parts by mass or less of the cannabinoid and 0.1 parts by mass or more and 60 parts by mass or less of the piperine per 100 parts by mass of the solvent.
[0020] The present invention also provides the liquid composition for electronic cigarettes, which further contains a flavorant.
[0021] The present invention also provides an electronic cigarette comprising the above-mentioned liquid composition for electronic cigarettes. Effect of the Invention
[0022] According to the present invention, the above problems and issues are solved, and cannabinoids and piperine are released by vaporizing or atomizing them using a heated electronic cigarette, and by inhaling them into the lungs, it is possible to provide the person who ingests them with a sleep effect consisting of a sleep-inducing effect and a wake-up effect, an anxiety-suppressing effect, a sedative effect, a pain-suppressing effect, a smoking cessation effect, and the like. The present invention is suitable (applicable) to both diseased and healthy individuals.
[0023] Specifically, it is effective for falling asleep and sleeping on the day of taking it, and helps you wake up better the next day (falling asleep and waking up more smoothly, improving the wake-up effect), providing effects similar to those of taking a sleeping pill. Furthermore, people who normally suffer from chronic pain can achieve pain suppression effects by practicing the present invention.
[0024] Furthermore, according to the present invention, since it can replace "smoking to ingest nicotine", it is possible to break away from nicotine dependence / smoking dependence while utilizing the psychological dependence (behavioral dependence) on smoking.
[0025] Piperine appears to enhance the effects of cannabinoids. When piperine is used in combination with cannabinoids, the beneficial effects of the cannabinoids are enhanced (for the same total amount) compared to when the amount of piperine used is converted to an increased amount of cannabinoids. Also, the inclusion of piperine allows the amount of cannabinoids used to be reduced.
[0026] Furthermore, by making the essential components of the liquid composition for electronic cigarettes of the present invention, including cannabinoids, piperine, and preferably caffeine and flavorings, all of them derived from plants, the composition can be used safely and the above-mentioned effects are enhanced. By not including tetrahydrocannabinol (THC) in the liquid composition for electronic cigarettes of the present invention, the composition is medically and legally (regulatory) acceptable, and the effects of the invention are excellent.
[0027] In addition, by setting the content concentration (ratio) of the cannabinoid and piperine in the liquid composition for electronic cigarettes of the present invention and the content ratio of the two to a specific range, the above-mentioned effects can be more suitably exhibited.
[0028] Furthermore, when caffeine is also taken in combination, calculation ability increases immediately after ingestion, and it also has a wake-up effect and alertness effect, such as being effective in waking up the next day (e.g., feeling refreshed). Furthermore, by using a specific fragrance in combination, the sleep-inducing effect, anxiety-reducing effect, sedative effect, pain-reducing effect, smoking cessation effect, etc. can be further enhanced. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0029] The present invention will be described below, however, the present invention is not limited to the specific embodiments below and can be modified as desired within the scope of the technical concept.
[0030] The liquid composition for electronic cigarettes of the present invention is a liquid composition for electronic cigarettes that releases active ingredients contained in the liquid composition by heating the liquid composition, and is characterized by containing at least cannabinoids contained in hemp stems or seeds, piperine, and a solvent.
[0031] <Electronic cigarettes> The electronic cigarette of the present invention may be any type that releases the active ingredient contained in the liquid composition by heating the liquid composition, and those having a system or structure used in commercially available electronic cigarettes or heat-not-burn cigarettes are also preferably used. The release is not particularly limited, and examples include atomization, vaporization by evaporation or sublimation, and release in the form of an aerosol.
[0032] The heating source is preferably a battery, and the wire may be any of Kanthal, Nichrome, stainless steel, nickel, titanium, etc. Also, a vaporizer may be used. The liquid composition for electronic cigarettes of the present invention may be directly placed in the electronic cigarette, may be in a cartridge format, or may be impregnated into a carrier such as absorbent cotton or nonwoven fabric.
[0033] The present invention also relates to an electronic cigarette characterized by having the following liquid composition for electronic cigarettes.
[0034] <Cannabinoids> "Cannabinoid" is a general term for chemicals contained in hemp (cannabis). The cannabinoids contained in the liquid composition for electronic cigarettes of the present invention may be extracted from hemp (cannabis), synthesized, or semi-synthesized by reacting an extract. The concept of "extracted from hemp" includes (can be used with) a single type of cannabinoid, (can be used with) a mixture of multiple (dozens of) cannabinoids, and (semi-)synthetic cannabinoid derivatives and their salts.
[0035] The cannabinoid in the present invention is preferably extracted from hemp (cannabis). Since the cannabinoid extracted from hemp leaves or flowers contains tetrahydrocannabinol (THC), which is legally restricted in some countries, the cannabinoid in the present invention is more preferably extracted from hemp stems or seeds, since it does not contain tetrahydrocannabinol (THC). Considering the Cannabis Control Act of Japan, the above-mentioned "hemp stalks or seeds" are particularly preferably those contained in "mature hemp stalks or seeds" because they contain absolutely no tetrahydrocannabinol (THC).
[0036] If tetrahydrocannabinol (THC) is contained, it may be subject to legal restrictions and may cause phenomena, symptoms, or effects that cannot be described as "favorable sleep effects, anxiety suppression effects, sedative effects, pain suppression effects, or sedative effects," and therefore may be unsuitable as the "cannabinoid" of the present invention. In other words, it is preferable that the liquid composition for electronic cigarettes of the present invention does not contain tetrahydrocannabinol (THC).
[0037] In the liquid composition for electronic cigarettes of the present invention, the cannabinoid preferably contains at least one cannabinoid selected from the group consisting of cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabielsoin (CBE), cannabigerol (CBG), and cannabidivarin (CBDV), extracted from the stems or seeds of hemp. The cannabinoid may be contained in one type or in two or more types.
[0038] <<Cannabidiol (CBD)>> Among them, it is more preferable to contain cannabidiol (CBD) as the main component of the cannabinoid. Here, the "main component" refers to a cannabinoid that is contained in an amount of 80% by mass or more relative to the total cannabinoids, preferably 90% by mass or more, more preferably 97% by mass or more, even more preferably 99% by mass or more, particularly preferably 99.5% by mass or more, and most preferably 99.9% by mass or more.
[0039] Furthermore, in the liquid composition for electronic cigarettes of the present invention, it is particularly preferable that cannabidiol (CBD) is contained at 100% by mass of the total cannabinoids, that is, the "cannabinoid" is only cannabidiol (CBD), and the most preferable liquid composition for electronic cigarettes is made by dissolving crystals of cannabidiol (CBD) extracted from hemp stems or seeds in a solvent described below. Being crystals means that the purity is high, and there is no risk of problems caused by the action of impurities contained therein. In other words, it is most preferable that the cannabinoid dissolved in the liquid composition for electronic cigarettes of the present invention is derived from crystals of cannabidiol (CBD) extracted from hemp stems or seeds.
[0040] <Piperine> The piperine contained in the liquid composition for electronic cigarettes of the present invention may be natural, extracted from pepper or the like, or (semi-)synthetic. However, piperine derived from natural products (pepper, etc.) is preferred, since all of the active ingredients in the liquid composition for electronic cigarettes of the present invention can be natural products and it is easy to obtain.
[0041] The method for extracting piperine from plants is not particularly limited, but it can be extracted by supercritical fluid extraction, subcritical fluid extraction, steam distillation, aqueous solvent extraction, organic solvent extraction, thermal sublimation, etc. Examples of the supercritical fluid include carbon dioxide.
[0042] The piperine dissolved in the liquid composition for electronic cigarettes of the present invention is preferably a crystal of piperine obtained from natural products such as pepper, because it has high purity and there is no risk of problems due to the action of impurities contained therein. Being a crystal means having high purity.
[0043] <Solvent> The liquid composition for electronic cigarettes of the present invention contains a solvent as an essential component, that is, the liquid composition for electronic cigarettes is a composition in which at least a cannabinoid and piperine are dissolved in the solvent.
[0044] The solvent preferably contains an alcohol-based solvent and / or water. The main component may be an alcohol-based solvent, water, or a "mixed solvent of water and an alcohol-based solvent". Among them, those having an alcohol-based solvent as the main component are preferred. Here, the "main component" is defined in the same way as above. Here, the alcohol-based solvent may be used alone or in combination of two or more.
[0045] The alcohol solvent is preferably one approved as a food additive, and more preferably a "naturally derived alcohol solvent" such as vegetable glycerin. Specifically, the alcohol solvent is preferably glycerin and / or glycol. The "glycerin" also includes polyglycerin such as diglycerin. Preferred examples of the glycol include propylene glycol, dipropylene glycol, and 1,3-butylene glycol. The glycol is preferably one having a boiling point higher than that of propylene glycol. The glycerin may be used alone or in combination of two or more. The glycol may be used alone or in combination of two or more.
[0046] <Caffeine> Although there is no particular limitation, it is also preferable that the liquid composition for electronic cigarettes of the present invention further contains caffeine. The caffeine may be so-called "pure caffeine" or may not be "pure caffeine", but "caffeine contained in plants and extracted from the plants" is easy to produce, and since it is of natural origin, the components contained in the liquid composition for electronic cigarettes of the present invention can be "all naturally derived".
[0047] Among these, those in which the caffeine is contained in plants are preferred, and those contained in (parts of) plants such as seeds contained in the fruits of coffee trees, guarana, cacao trees, etc.; tea leaves; etc. are easy to produce, and being of natural origin, the components contained in the liquid composition for electronic cigarettes of the present invention can be "all naturally derived", which is even more preferred.
[0048] As the caffeine, it is also preferable to use the caffeine contained in foods and beverages such as coffee, coffee drinks, guarana, guarana drinks, green tea, oolong tea, black tea, mate tea, cocoa, and chocolate as it is. In this case, the liquid composition for electronic cigarettes may contain the "water" and "ingredients other than caffeine" contained in these foods and beverages as they are, and the water contained therein can also be used as a "solvent" as described below (it can also be considered as "one of the solvents").
[0049] The method for extracting caffeine from plants is not particularly limited, but it can be extracted by supercritical fluid extraction, subcritical fluid extraction, steam distillation, aqueous solvent extraction, organic solvent extraction, thermal sublimation, etc. Examples of the supercritical fluid include carbon dioxide.
[0050] When the liquid composition for electronic cigarettes of the present invention further contains caffeine, the "calculation speed" immediately after ingestion increases significantly, and it also has an effect on waking up the next day (wake-up effect (feeling refreshed, etc.)). Furthermore, the awakening effect is obtained simultaneously (in parallel) with the original sleep-inducing and sedative effects.
[0051] <Fragrance> The liquid composition for electronic cigarettes of the present invention is not particularly limited, but preferably further contains a flavoring. As the flavoring, any of natural flavorings, synthetic flavorings, and blended flavorings can be used. In addition, flavors (food additives) and fragrances (cosmetic flavorings) can be used. The types of fragrances include citrus, floral, fruit, milk, chypre, oriental, (luxury) food and beverage, pre-made (luxury) smoking accessories, vanilla, mint, sweetener, spice, nut, and alcoholic beverages.
[0052] Among these, preferred are flavors that give a refreshing sensation, such as citrus, fruit, and mint flavors; flavors that give a relaxing sensation, such as flavors for (luxury) foods and beverages, such as chocolate, milk, and coffee; and flavors that give a sweet sensation, such as vanilla, floral, and sweetener flavors.
[0053] Although not limited thereto, it is particularly preferable that the fragrance contains terpenes such as limonene and β-caryophyllene; terpenoids; and the like.
[0054] Furthermore, as the flavoring, spearmint extract, menthol, substances having the flavor (aroma) of cannabis, substances having the flavor (aroma) of tobacco, and the like are also preferred. The "substance having the flavor (aroma) of cannabis" is preferably a substance other than "a substance contained in mature hemp stems or seeds," and is particularly preferably a substance not derived from hemp. Also, the "substance having the flavor (aroma) of tobacco" is preferably a substance other than nicotine.
[0055] By incorporating a fragrance, the sleep effect (sleep-inducing effect, waking-up effect, etc.), anxiety suppressing effect, calming effect, smoking cessation effect, etc. can be further enhanced, and the preference effect can also be enhanced.
[0056] <Other ingredients> The liquid composition for electronic cigarettes of the present invention may contain "other ingredients" in addition to the above-mentioned ingredients. Examples of "other ingredients" include edible oils such as jojoba oil, grapeseed oil, sesame oil, coconut oil, and olive oil; naturally occurring ingredients such as beeswax, sugar, oxytocin, tyrosine, tryptophan, and melatonin; and herbal medicines derived from plants.
[0057] <Content, content ratio> In the liquid composition for electronic cigarettes of the present invention, the cannabinoid and piperine are preferably contained in a ratio by mass ranging from 9.5:0.5 to 2:8, more preferably in a ratio by mass ranging from 9.4:0.6 to 3:7, even more preferably in a ratio by mass ranging from 9.3:0.7 to 5:5, particularly preferably in a ratio by mass ranging from 9.2:0.8 to 6:4, and most preferably in a ratio by mass ranging from 9:1 to 7:3.
[0058] If the amount of cannabinoid is less than the above ratio relative to the total amount of cannabinoid and piperine, it is difficult to obtain the effects of the cannabinoid. In that case, although the amount of piperine is relatively high, the increased amount of piperine may make it difficult to enhance the "effect of the cannabinoid". Conversely, if the amount of piperine is too small compared to the total amount of cannabinoid and piperine, the enhancement effect of "the effect of cannabinoid" by piperine may not be obtained.
[0059] The cannabinoid is preferably contained in an amount of 1 part by mass to 300 parts by mass, more preferably 1.3 parts by mass to 200 parts by mass, even more preferably 2 parts by mass to 100 parts by mass, particularly preferably 3 parts by mass to 30 parts by mass, and most preferably 4 parts by mass to 10 parts by mass, relative to 100 parts by mass of the solvent. Note that the above "parts by mass of the solvent" includes the mass of the dilution solvent contained therein, for example, when the flavoring is used or obtained by diluting it in advance. If the concentration is above the lower limit, sleep effects, anxiety suppression effects, sedative effects, pain suppression effects, smoking cessation effects, etc. can be suitably obtained, and if the concentration is below the upper limit, there are no problems caused by the above effects being too strong, and the cannabinoids are not wasted.
[0060] Furthermore, the piperine is preferably contained in an amount of 0.1 to 60 parts by mass, more preferably 0.2 to 40 parts by mass, even more preferably 0.4 to 20 parts by mass, particularly preferably 0.6 to 10 parts by mass, and most preferably 1 to 5 parts by mass, relative to 100 parts by mass of the solvent. If it is more than the lower limit, the effect of the cannabinoid can be increased. That is, a synergistic effect between the cannabinoid and piperine is achieved. On the other hand, if it is less than the upper limit, the unpleasant taste of piperine is not noticeable and the flavor is not impaired. In addition, even if piperine is used in an amount exceeding the upper limit, the "effect of the cannabinoid" by piperine cannot be enhanced, and piperine may be wasted.
[0061] Furthermore, when caffeine is further contained, the caffeine is preferably contained in an amount of 0.01 part by mass or more and 10 parts by mass or less, more preferably 0.03 part by mass or more and 4 parts by mass or less, even more preferably 0.1 part by mass or more and 2 parts by mass or less, and particularly preferably 0.2 part by mass or more and 1 part by mass or less, relative to 100 parts by mass of the solvent. If the amount is more than the upper limit, the sleep-inducing, anxiety-reducing, sedative, pain-reducing, and smoking cessation effects of cannabinoids may not be fully exerted.
[0062] Furthermore, when a fragrance is further contained, the fragrance is preferably contained in an amount of 0.001 part by mass or more and 2 parts by mass or less, more preferably 0.01 part by mass or more and 1.3 parts by mass or less, and particularly preferably 0.1 part by mass or more and 1 part by mass or less, relative to 100 parts by mass of the solvent. It is also preferable to dilute the fragrance with the solvent to about 1% by mass, and mix the diluted solution in an amount 100 times the above value.
[0063] <Manufacturing method> The liquid composition for electronic cigarettes of the present invention can be prepared by dissolving a cannabinoid, piperine, and preferably caffeine and / or a flavoring in a solvent. The cannabinoids can be formulated in the form of an extract or oil containing them, or can be formulated in the form of cannabinoid crystals (mixtures) such as cannabidiol (CBD) crystals (single compound form) and dissolved for use. For the reasons mentioned above, it is preferable to use (formulate) crystals.
[0064] For the reasons mentioned above, it is preferable to use (combine) piperine in crystal form.
[0065] When caffeine is added, it can be added in the form of an extract containing it or a caffeine drink, or it can be added in the form of pure caffeine and dissolved for use.
[0066] When the above-mentioned fragrances and "other ingredients" are contained, the method of blending them is not particularly limited and is carried out according to the usual method. The components may be mixed and stirred at the same time to dissolve, or one component may be mixed and dissolved first, and then another component may be mixed and dissolved.
[0067] The dissolution temperature, dissolution time, stirring conditions, etc. are not particularly limited and are carried out according to conventional methods. The dissolution temperature is preferably 0°C or higher and 120°C or lower, more preferably 15°C or higher and 100°C or lower, and particularly preferably 30°C or higher and 80°C or lower. The dissolution time or stirring time is preferably from 1 minute to 2 hours, more preferably from 2 minutes to 1 hour, and particularly preferably from 5 minutes to 40 minutes. EXAMPLES
[0068] The present invention will be described in more detail below with reference to examples. However, the present invention is not limited to these examples as long as it does not depart from the gist of the present invention.
[0069] Preparation Example 1 <Contains cannabinoids and piperine> A solvent was prepared by mixing 1.5 parts by mass of glycerin obtained from plants, 6.0 parts by mass of propylene glycol, and 0.5 parts by mass of purified water, and while maintaining the liquid temperature in the range of 30°C to 50°C, 0.50 parts by mass of cannabidiol (CBD) crystals extracted from hemp stems and seeds were added to the solvent and stirred for 20 minutes. Next, 0.10 parts by mass of piperine crystals were added and stirred for 20 minutes. Thereafter, 2.0 parts by mass of Green Apple Flavor (manufactured by Takasago International Corporation) (an alcohol solution containing approximately 1% by mass of the active ingredient), which is an ethanol solution containing 1% by mass of the active ingredient, was added and mixed and stirred uniformly to prepare a liquid composition for electronic cigarettes (1).
[0070] Preparation Example 2 <Contains cannabinoids (does not contain piperine)> A liquid composition for electronic cigarettes (2) was prepared in the same manner as in Preparation Example 1, except that piperine was not used and 4.0 parts by mass of cannabidiol (CBD) crystals were used.
[0071] Preparation Example 3 <Contains piperine (does not contain cannabinoids)> In Preparation Example 1, an e-cigarette liquid composition (3) was prepared in the same manner as in Preparation Example 1, except that 4.0 parts by mass of crystalline piperine was used instead of cannabidiol (CBD).
[0072] Preparation Example 4 <Does not contain both cannabinoids and piperine> In Preparation Example 1, an e-cigarette liquid composition (4) was prepared in the same manner as in Preparation Example 1, without using either cannabidiol (CBD) or piperine. That is, the e-cigarette liquid composition (4) contains only the solvent (glycerin, propylene glycol, and water) and the flavoring agent.
[0073] Preparation Example 5 <Contains cannabinoids and piperine (does not contain flavoring agent)> In Preparation Example 1, an e-cigarette liquid composition (5) was prepared in the same manner as in Preparation Example 1, except that no flavoring agent was used.
[0074] Evaluation Example 1 <Evaluation method for e-cigarette liquid compositions (1) and (2)> Five types of e-cigarette liquid compositions (1) to (5) were filled into a rechargeable, cylindrical e-cigarette device manufactured by VPOCERA, and were inhaled by "a plurality of each subject" who complained of the following symptoms for each evaluation item. The subjects were inhaled without being informed of the content.
[0075] <Group A: Sleep effect (subjects and evaluation method for bedtime effect and smoothness of waking up (waking-up effect))> Two people (subjects in Group A) who usually felt insomnia and regularly took sleeping pills (sleep induction agents) were inhaled as follows. During the evaluation, they were asked to stop taking sleeping pills (sleep induction agents). On the first to third days, they were inhaled with the e-cigarette liquid composition (2). On the next fourth to fifth days, they were not inhaled and were given a break. On the next sixth to eighth days, they were inhaled with the e-cigarette liquid composition (1). The evaluation results are shown in Table 1.
[0076] <Group A: Criteria for Judging Sleep Effects (Bedtime Effect and Smoothness of Wake-up (Wake-up Effect))> <<Bedtime Effect (Bedtime Situation)>> ◎: Able to go to bed quickly ○: Able to go to bed relatively early △: Able to go to bed to the same extent as a normal person (able to fall asleep) ×: Had difficulty falling asleep and couldn't go to bed (no effect)
[0077] <<Wake-up Effect (Wake-up Situation)>> ◎: Able to wake up very early and in a good mood ○: Able to wake up relatively early △: Able to wake up to the same extent as a normal person (able to wake up) ×: Had difficulty waking up and was in a bad mood
[0078] <Group B: Subjects and Evaluation Method of Pain Inhibitory Effect> For three people who usually go to the hospital due to chronic pain (subjects in Group B), similar to the subjects in Group A who evaluated the above sleep effects, first, they were asked to inhale the e-liquid composition (2) for electronic cigarettes, and after a two-day interval, they were asked to inhale the e-liquid composition (1) for electronic cigarettes. During the evaluation, they were asked to stop taking analgesics and the like.
[0079] <Group B: Criteria for Judging Pain Inhibitory Effect> ◎: No pain was felt at all ○: Almost no pain was felt △: Pain was felt, but less than usual ×: Pain was felt and there was no change from usual (no pain inhibitory effect)
[0080] <Group C: Subjects and Evaluation Method of Anxiety Inhibitory Effect (Anxiolytic Effect, Sedative Effect)> For two subjects with anxiety neurosis who usually have anxiety disorders (subjects in group C), similar to the subjects in group A who evaluated the sleep effect, first, they were asked to inhale the e-cigarette liquid composition (2), and after a two-day interval, they were asked to inhale the e-cigarette liquid composition (1). During the evaluation, they were asked to discontinue taking antipsychotics, sedatives, etc.
[0081] <Group C: Criteria for Judging the Anxiety Inhibitory Effect (Anxiolytic Effect, Sedative Effect)> ◎: No anxiety was felt at all. ○: Almost no anxiety was felt. △: Anxiety was felt, but less than usual. ×: Anxiety was felt and there was no change from usual (no effect on anxiety inhibition).
[0082] <Group D: Subjects and Evaluation Method for Smoking Cessation Effect> For three subjects who usually smoke habitually (subjects in group D), similar to the subjects in group A who evaluated the sleep effect, first, they were asked to inhale the e-cigarette liquid composition (2), and after a two-day interval, they were asked to inhale the e-cigarette liquid composition (1).
[0083] <Group D: Criteria for Judging the Smoking Cessation Effect> ◎: No longer felt like smoking at all (completely successful in quitting smoking). ○: No longer felt much like smoking (successful in quitting smoking). △: Sometimes felt like smoking (slightly effective in quitting smoking). ×: Felt like smoking and there was no change from usual (no effect on quitting smoking).
[0084] Evaluation Example 2 <Evaluation Method for E-Cigarette Liquid Compositions (1) and (5)> In the above Evaluation Example 1, except that the e-cigarette liquid composition (5) was used instead of the e-cigarette liquid composition (1), the evaluation items were evaluated in the same manner as in Evaluation Example 1, and judged according to the same above-mentioned criteria. That is, on the first to third days, they were asked to inhale the e-cigarette liquid composition (2). For the next 4-5 days, I was given a break without any suction. On the following 6 to 8 days, the subjects were asked to inhale the electronic cigarette liquid composition (5). The evaluation results are shown in Table 1.
[0085] Evaluation example 3 <Evaluation method of electronic cigarette liquid compositions (3) and (4)> Since the electronic cigarette liquid compositions (3) and (4) were not effective enough to require a comparison with the electronic cigarette liquid composition (1) (because they were overwhelmingly worse and did not require a comparative evaluation), the subjects were asked to smoke the electronic cigarette liquid compositions (3) and (4) from the first 1 to 3 days. Each evaluation item was evaluated in the same manner and judged according to the same judgment criteria described above. The evaluation results are shown in Table 1.
[0086] [Table 1]
[0087] <Evaluation results of evaluation examples 1 to 3 of electronic cigarette liquid compositions (1) to (5) (Table 1)> For all items evaluated, the combination of CBD and piperine (liquid composition for electronic cigarettes (1)) had a higher effect (better effect) than CBD alone (liquid composition for electronic cigarettes (2)). We also confirmed that the enhancing effect of piperine was greater when taken via the lungs than when taken orally.
[0088] The composition containing piperine but not CBD (liquid composition for electronic cigarettes (3)) showed no effect at all. It was found that the inclusion of piperine enhances the various effects of CBD mentioned above. When the flavoring was removed from the electronic cigarette liquid composition (1) (electronic cigarette liquid composition (5)), the effect was slightly lower than that of the electronic cigarette liquid composition (1) in all evaluation items, but the results were still extremely good.
[0089] Preparation Example 6 Instead of blending "crystals of cannabidiol (CBD) extracted from hemp stalks and seeds" as in Preparation Examples 1, 2, and 5 above, the same amount of so-called "full spectrum" extracted from mature hemp stalks and seeds, which does not contain tetrahydrocannabinol (THC) but contains other cannabinoids, was blended in the same manner as in Preparation Examples 1, 2, and 5, and otherwise liquid compositions (1'), (2'), and (5') for electronic cigarettes were prepared in the same manner as in Preparation Examples 1 to 5.
[0090] <Evaluation results of non-crystalline CBD content> When liquid compositions (1'), (2'), and (5') for electronic cigarettes were evaluated according to Evaluation Example 1, the evaluation results were slightly inferior to those of liquid compositions (1), (2), and (5) for electronic cigarettes in Table 1, but the results were almost the same as those shown in Table 1.
[0091] Preparation Example 11 <Contains cannabinoids and piperine> A solvent was prepared by mixing 7 g of vegetable glycerin and 3 g of propylene glycol. While keeping the liquid temperature in the range of 30°C to 80°C, 0.4 g of cannabidiol (CBD) crystals extracted from hemp stems and seeds was added to the solvent and stirred for 20 minutes. Then, 0.1 g of piperine crystals was added and mixed and stirred uniformly to prepare a liquid composition for electronic cigarettes (11).
[0092] Preparation Example 12 <Contains cannabinoids> A liquid composition for electronic cigarettes (12) was prepared in the same manner as in Preparation Example 11, except that piperine crystals were not added.
[0093] Preparation Example 13 <Contains cannabinoids, piperine and caffeine> A liquid composition for electronic cigarettes (13) was prepared in the same manner as in Preparation Example 11, except that 0.03 g of pure caffeine was further added. Thereafter, 3 drops (0.1 g) of coffee flavor (manufactured by Capella) were added using a dropper, and the mixture was mixed and stirred uniformly to prepare a liquid composition for electronic cigarettes (13).
[0094] Preparation Example 14 <Contains cannabinoids and caffeine> A liquid composition for electronic cigarettes (14) was prepared in the same manner as in Preparation Example 13, except that piperine crystals were not added.
[0095] Evaluation Example 11 <Evaluation method> Four types of liquid compositions (11) to (14) for electronic cigarettes were filled into a rechargeable, cylindrical electronic cigarette device manufactured by JUSTFOG, measuring H113.5 × W20 × D20 mm and 82.9 g, and five subjects were asked to inhale each of the four types without knowing the contents. The evaluation was conducted twice (over three days), and subjects were asked to record their sleeping habits on that day (sleep effect) and their waking habits the next day (waking effect).
[0096] <<Criteria for judging sleep status (sleep effectiveness)>> ☆: I was able to fall asleep very quickly. ◎: I was able to get to bed quickly. ○: I was able to go to bed relatively early. △: I was able to go to bed as usual (I was able to fall asleep) ×: I had trouble falling asleep and couldn't get to sleep.
[0097] <<Criteria for judging wake-up status (wake-up effect)>> ◎: I woke up feeling great. ○: I was able to wake up relatively early. △: I was able to wake up as usual (waking up) ×: I had a hard time getting up and I didn't feel well.
[0098] <Results of Evaluation Example 11 for Liquid Compositions for Electronic Cigarettes of Preparation Examples 11 to 14> The results of Evaluation Example 11 for the four types of liquid compositions for electronic cigarettes (11) to (14) are summarized in Table 2 below. In addition, in Evaluation Example 11, the sleep effect (effect on going to sleep and effect on waking up) tends to be judged more favorably than Evaluation Example 1 due to the "difference only in the evaluation method and judgment criteria" (Evaluation Example 1 has a stricter evaluation method and judgment criteria than Evaluation Example 11).
[0099] [Table 2]
[0100] Piperine, with or without caffeine, increased the ability to fall asleep and wake up (enhanced sleep effect) compared to those without piperine. [Industrial Applicability]
[0101] An electronic cigarette using the liquid composition for electronic cigarettes of the present invention releases the liquid composition for electronic cigarettes of the present invention by heating and evaporating or atomizing it, and by inhaling it into the lungs, the person who ingests it can obtain a sleep effect, an anxiety suppressing effect, a sedative effect, a pain suppressing effect, an anti-smoking effect, etc. Therefore, the present invention is suitable for both people with diseases and healthy people, and can be widely used not only in the field of electronic cigarettes, but also in the fields of medical care, anti-smoking products, luxury goods, sports, qualification examinations, business, etc.
Claims
1. A liquid composition for electronic cigarettes that releases a cannabinoid, which is an active ingredient contained in the liquid composition, by heating the liquid composition, The active ingredient contains cannabidiol (CBD) extracted from mature cannabis as the main active ingredient, and further contains at least piperine and a solvent. This liquid composition for electronic cigarettes is characterized in that the cannabidiol (CBD) is derived from crystals, thereby reducing the amount of tetrahydrocannabinol (THC).
2. A liquid composition for electronic cigarettes as described in claim 1, which is substantially free of tetrahydrocannabinol (THC).
3. A liquid composition for an electronic cigarette as claimed in claim 1 or claim 2, except when it contains a liquid composition from a cannabis plant which has reduced Δ9-tetrahydrocannabinolic acid compared to a control cannabis plant by downregulating expression of tetrahydrocannabinolic acid synthase (SEQ ID NO: 21).
4. The liquid composition for electronic cigarettes according to any one of claims 1 to 3, wherein the solvent contains an alcohol-based solvent and / or water.
5. The liquid composition for electronic cigarettes according to claim 4, wherein the alcohol-based solvent is glycerin and / or glycol.
6. The liquid composition for electronic cigarettes according to any one of claims 1 to 5, wherein the cannabinoid and the piperine are contained in a ratio of 9:1 to 7:3 by mass.
7. The liquid composition for electronic cigarettes according to any one of claims 1 to 6, comprising 1 part by mass or more and 300 parts by mass or less of the cannabinoid and 0.1 parts by mass or more and 60 parts by mass or less of the piperine relative to 100 parts by mass of the solvent.
8. The liquid composition for electronic cigarettes according to any one of claims 1 to 7, further comprising caffeine.
9. A liquid composition for electronic cigarettes as described in claim 8, wherein the piperine and the caffeine are contained in a plant and extracted from the plant.
10. The liquid composition for electronic cigarettes according to any one of claims 1 to 9, further comprising a flavoring.
11. An electronic cigarette comprising the liquid composition for electronic cigarettes according to any one of claims 1 to 10.
Citation Information
Patent Citations
Cannabinoid component-containing composition extracted from industrial hemp and application of cannabinoid component-containing composition in tobacco products
CN110367581A
Methods and kits for controlling bleeding
JP2007525431A
Hemp seed oil and brown algae derived health food
JP2017079615A
Cannabinoid compositions and uses
JP2018150334A
Compositions and methods for selective GI tract delivery
JP2019513146A
